The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population

被引:30
|
作者
Wu, Heming [1 ,2 ,3 ,4 ]
Huang, Qingyan [1 ,2 ,3 ,4 ]
Yu, Zhikang [1 ,2 ,3 ,4 ]
Wu, Hailing [1 ,2 ,3 ,4 ]
Zhong, Zhixiong [1 ,2 ,3 ,4 ,5 ]
机构
[1] Sun Yat Sen Univ, Huangtang Hosp, Meizhou Peoples Hosp, Meizhou Hosp,Meizhou Acad Med Sci,Ctr Precis Med, Meizhou, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou Peoples Hosp, Meizhou Hosp,Meizhou Acad Med Sci,Huangtang Hosp, Meizhou, Peoples R China
[3] Sun Yat Sen Univ, Guangdong Prov Engn & Technol Res Ctr Clin Mol Di, Meizhou Peoples Hosp, Meizhou Hosp,Meizhou Acad Med Sci,Huangtang Hosp, Meizhou, Peoples R China
[4] Sun Yat Sen Univ, Guangdong Prov Engn & Technol Res Ctr Mol Diagnos, Meizhou Peoples Hosp, Meizhou Hosp,Meizhou Acad Med Sci,Huangtang Hosp, Meizhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Cardiovasc Dis, Meizhou Peoples Hosp, Meizhou Hosp,Meizhou Acad Med Sci,Huangtang Hosp, Meizhou, Peoples R China
关键词
Apolipoprotein E; Gene polymorphism; Cerebral infarction; Relationship; Hakka; APOLIPOPROTEIN-E POLYMORPHISM; LIPID LEVELS; OATP-C; RISK; SUSCEPTIBILITY; EPIDEMIOLOGY; VARIANTS; THERAPY; DISEASE; STROKE;
D O I
10.1186/s12944-020-01379-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Apolipoprotein E (ApoE) and solute carrier organic anion transporter family member 1B1 (SLCO1B1) regulate lipid metabolism. However, the relationship between genetic polymorphisms ofAPOEandSLCO1B1and cerebral infarction (CI) remains unclear. Methods A total of 938 CI patients and 1028 control participants were included in the study. The rs429358 and rs7412 single nucleotide polymorphisms (SNPs) in theAPOEgene and rs2306283 and rs4149056 SNPs in theSLCO1B1gene were analyzed by fluorescence polymerase chain reaction (PCR). Results The genotype e3/e3 was the most commonAPOEgenotype, with e3 being the allele with the highest frequency, followed by e4 and e2. Statistically significant differences of genotype e2/e2 (chi(2) = 3.866,P = 0.049), e2/e3 (chi(2) = 20.030,P < 0.001), e3/e4 (chi(2) = 16.960,P < 0.001), and e4/e4 (chi(2) = 4.786,P = 0.029) between CI patients and controls were detected. TheSLCO1B1genotype *1b/*1b and haplotype *1b showed the highest frequency in the study sample. There was no statistically significant difference in the frequencies ofSLCO1B1genotypes and haplotypes among CI patients comparing with controls. Moreover, epsilon 4 carriers had significantly higher low-density lipoprotein-cholesterol (LDL-C) and apolipoprotein B (Apo-B) and lower apolipoprotein A1 (Apo-A1)/Apo-B levels than epsilon 2 and epsilon 3 carriers, but epsilon 2 carriers showed lower LDL-C and Apo-B and higher Apo-A1/Apo-B than epsilon 3 and epsilon 4 carriers. Further, logistic regression analysis revealed that high LDL-C, high ApoB, smoking, hypertension and the epsilon 4 allele were risks for the presence of CI. Conclusions This study indicated that theAPOESNPs rs429358 and rs7412 may be associated with susceptibility to cerebral infarction in southern Chinese Hakka population.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] POTENTIAL APPLICATION OF THE VARIATION SITES, RS429358 AND RS7412, IN THE APOE GENE FOR EVALUATING THE RISK FACTORS, LIPID DISORDERS, CLINICAL SEVERITY AND PROGNOSIS IN PATIENTS WITH ST-SEGMENT ELEVAT
    Inozemtseva, A.
    Kashtalap, V.
    Argunova, A.
    Gordeeva, L.
    Barbarash, O.
    ATHEROSCLEROSIS, 2018, 275 : E201 - E201
  • [22] Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer
    Kamio, Hidenori
    Uchiyama, Toshitaka
    Kanno, Hitoshi
    Onoe, Yoshiko
    Saito, Kayoko
    Kameoka, Shingo
    Kamio, Takako
    Okamoto, Takahiro
    PHARMACOGENOMICS, 2019, 20 (05) : 353 - 366
  • [23] SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma
    Yang, Lin
    Wu, Hui
    van Gelder, Teun
    Matic, Maja
    Ruan, Jun-Shan
    Han, Yong
    Xie, Rui-Xiang
    PHARMACOGENOMICS, 2017, 18 (17) : 1557 - 1562
  • [24] Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia
    Khine, Htet
    Yuet, Wei Cheng
    Adams-Huet, Beverley
    Ahmad, Zahid
    AMERICAN HEART JOURNAL, 2016, 179 : 1 - 9
  • [25] Frequency of the SLCO1B1 (rs4149056) polymoR. Ph. ism in Caucasians compared to Mexican Americans.
    Kidd, Robert
    Wright, Tatiana
    PHARMACOTHERAPY, 2017, 37 (06): : E55 - E56
  • [26] SLCO1B1 rs4149056 PHENOME-WIDE ASSOCIATION STUDY WITH SURVEY DATA FROM THE HARVARD PERSONAL GENOME PROJECT.
    McDonough, C. W.
    Chase, P. B.
    Loiacono, A.
    Waugh, S.
    Modave, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S79 - S79
  • [27] Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome
    Li, Chao
    Shi, Yuhua
    You, Li
    Wang, Laicheng
    Chen, Zi-Jiang
    MOLECULAR HUMAN REPRODUCTION, 2011, 17 (03) : 193 - 198
  • [28] SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
    Toralf Reimer
    Sarah Kempert
    Bernd Gerber
    Hans-Jürgen Thiesen
    Steffi Hartmann
    Dirk Koczan
    BMC Cancer, 16
  • [29] SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
    Reimer, Toralf
    Kempert, Sarah
    Gerber, Bernd
    Thiesen, Hans-Juergen
    Hartmann, Steffi
    Koczan, Dirk
    BMC CANCER, 2016, 16
  • [30] The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia
    Bosco, Giosiana
    Barbagallo, Francesco Di Giacomo
    Di Marco, Maurizio
    Miano, Nicoletta
    Scilletta, Sabrina
    Spampinato, Salvatore
    Vitale, Alessio
    Di Bella, Federica
    Montalbano, Maria
    Di Mauro, Stefania
    Filippello, Agnese
    Scamporrino, Alessandra
    Milluzzo, Agostino
    Di Pino, Antonino
    Frittitta, Lucia
    Purrello, Francesco
    Piro, Salvatore
    Scicali, Roberto
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15